| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.8M | -57.6% |
| SG&A Expense | $8.6M | -1.3% |
| Operating Income | -$19.6M | -28.3% |
| Pre-tax Income | -$14.0M | +8.6% |
| Income Tax | $0 | — |
| Net Income | -$14.0M | +8.6% |
| EPS (Basic) | -$5.43 | -722.7% |
| EPS (Diluted) | -$5.43 | -722.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.4M | +103.6% |
| Current Assets | $33.5M | +102.2% |
| Total Assets | $33.5M | +99.6% |
| Current Liabilities | $11.8M | +446.3% |
| Total Liabilities | $11.8M | +435.1% |
| Stockholders' Equity | $21.8M | +49.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.7M | +22.6% |
| Capital Expenditures | $3K | +0.0% |
| Investing Cash Flow | $8K | +101.4% |
| Financing Cash Flow | $28.7M | +30.2% |
| Free Cash Flow | -$11.7M | +22.6% |